| Prev Close | 1.76 |
| Open | 1.71 |
| Day Low/High | 1.58 / 1.75 |
| 52 Wk Low/High | 0.21 / 1.57 |
| Volume | 4.68M |
Novan, Inc. (NOVN)
1.69
0.07
4.00
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 141.51B |
| Market Cap | 240.57M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Could These 9 Drugs Gain FDA Approval in the Age of Trump?
Nine biotech and drug companies want FDA approval, but need changed standards to get it.
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
The firms all have drugs they want the feds to bend the rules to approve.
Novan Only Piercing the Skin of Its Potential Says CEO
With a pair of Phase III trials coming up for its dermatological drug, Novan CEO Nate Stasko says the company is merely piercing the skin of its long-term potential.
